Letters Multidisciplinary team meetings

Having both patient advocates and patients at the MDT meeting might be useful

BMJ 2015; 351 doi: https://doi.org/10.1136/bmj.h5285 (Published 08 October 2015) Cite this as: BMJ 2015;351:h5285
  1. Ceinwen Giles, director1
  1. 1Shine Cancer Support, London, UK
  1. ceinwen.giles{at}gmail.com

Eigenmann’s recommendation that patients’ advocates attend the multidisciplinary team (MDT) meeting, not patients themselves, is interesting.1

Of those patients with cancer who know what an MDT is, many do not understand why they cannot attend a meeting at which they will be discussed. And many patients do not even understand what an MDT is. When you’re first diagnosed …

View Full Text

Log in

Log in through your institution


* For online subscription